Additionally, studies have shown that the CSF of glioma patients contains differentially enriched metabolites such as lactic acid, malic acid, succinate, and phosphoenolpyruvate compared to that of control patients, with variations observed based on the IDH status of GBM patients [279]. This evidence concerns the gene IDH1 and glioblastoma.